News

News

Icon LISA News = LISA News
11.08.2022
Valneva Reports H1 2022 Results and Provides Corporate Updates
11.08.2022
Evercyte human cells as in vitro test systems
11.08.2022
Nabriva Therapeutics Completes Patient Enrollment in Phase 1 Trial of XENLETA® (lefamulin) in Adult Patients with Cystic Fibrosis
11.08.2022
HOOKIPA Pharma Reports Second Quarter 2022 Financial Results and Corporate Updates
10.08.2022
F2G Announces $70 Million Financing to Advance Development and Commercialization of New Antifungal Agent Olorofim
09.08.2022
Pfizer and Valneva Initiate Phase 3 Study of Lyme Disease Vaccine Candidate VLA15
09.08.2022
Brustkrebs: Neuer Wirkstoff lässt Gehirnmetastasen schrumpfen
05.08.2022
Nabriva Therapeutics Reports Second Quarter 2022 Financial Results and Provides a Corporate Update
03.08.2022
Kinder mit Krebs reden täglich bei Therapie mit
03.08.2022
QUANTRO Therapeutics kooperiert mit Boehringer Ingelheim in der Entwicklung von Wirkstoffkandidaten zur Transkriptionsregulation